Back to top
more

ResMed (RMD)

(Delayed Data from NYSE)

$210.91 USD

210.91
411,980

-0.65 (-0.31%)

Updated Jun 7, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 248)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for RMD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

ResMed Inc. [RMD]

Reports for Purchase

Showing records 501 - 520 ( 528 total )

Company: ResMed Inc.

Industry: Medical - Products

Record: 501

08/02/2013

Company Report

Pages: 8

Exceeded Q4 FY2013 estimates, maintain HOLD and $49.50PT

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 502

07/31/2013

Company Report

Pages: 7

Q2 CY2013 Feltl CPAP Project 2005-2013: ~12,000 patient survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 503

04/26/2013

Company Report

Pages: 9

Beats on EPS, but mask growth hides, maintain HOLD lower PT to $45

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 504

04/15/2013

Company Report

Pages: 7

Q1 CY2013 Feltl CPAP Project 2005-2013: ~12,000 patient survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 505

01/25/2013

Company Report

Pages: 8

The horse has plenty of puff - ResMed beats top- and bottom-line estimates

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 506

01/18/2013

Company Report

Pages: 7

Q4 CY2012 Feltl CPAP Project 2005-2012: 11,000+ patient survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 507

10/26/2012

Company Report

Pages: 8

Q1 FY2013 EPS ahead of expectations, sales fall short of estimates

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 508

10/22/2012

Company Report

Pages: 7

Q2 CY2012 Feltl CPAP Project 2005-2012: 11,000+ patient survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 509

07/19/2012

Company Report

Pages: 7

Q2 CY2012 Feltl CPAP Project 2005-2012: 10,000+ patient survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 510

04/27/2012

Company Report

Pages: 8

RMD ResMed beats handily, margin expansion continued; raising rating to BUY, PT to $38

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 511

04/11/2012

Company Report

Pages: 7

RMD Q1 2012 Feltl CPAP Project: Survey of 10,000+ users

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 512

03/28/2012

Company Report

Pages: 8

RMD Quantifying the Medicare CPAP supplier widespread prepayment review

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 513

03/26/2012

Industry Report

Pages: 10

Medical Device-notes from first annual Irvine/San Diago " Bus Tour "This report contains brief updates on the following: ELGX, DXCM, CYTX, GPRO, NUVA, RMD, ALR, MASI, SGNT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 514

02/06/2012

Company Report

Pages: 6

Medical device excise tax skips ResMed

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 515

01/27/2012

Company Report

Pages: 8

RMD ResMed Q2 FY2012: High end products awaken margin expansion

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 516

01/17/2012

Company Report

Pages: 7

RMD Feltl CPAP Project 2005 2011: 4,400+ patient survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 517

01/03/2012

Industry Report

Pages: 7

Feltl and Company Best Ideas 2012

Provider: FELTL & COMPANY

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 518

12/20/2011

Company Report

Pages: 10

RMD Take a deep breath: ResMed undervalued, upgrading to STRONG BUY

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 519

10/25/2011

Company Report

Pages: 8

RMD Leaving money on the table, ResMed meets on EPS, misses on revenue

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: ResMed Inc.

Industry: Medical - Products

Record: 520

10/20/2011

Company Report

Pages: 7

Q1 2012 preview: FX, buyback imply outperformance

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party